Literature DB >> 2736096

Actinic cheilitis. A prospective study comparing four treatment methods.

J K Robinson1.   

Abstract

Forty patients with actinic cheilitis were treated with one of four modalities: topical fluorouracil, chemical peel with trichloroacetic acid, lip shave, or carbon dioxide laser ablation of the vermilion. Patients treated with lip shave or carbon dioxide laser ablation had no recurrence of the problem during a 4-year period. While the lip shave procedure offers the advantage of histologic examination of the specimen, the patients treated with the laser ablation had fewer postoperative complications.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2736096     DOI: 10.1001/archotol.1989.01860310086029

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  5 in total

1.  A case of metastatic squamous cell carcinoma arising from actinic cheilitis.

Authors:  Na Hyun Kwon; Si Yong Kim; Gyong Moon Kim
Journal:  Ann Dermatol       Date:  2011-02-28       Impact factor: 1.444

2.  Diclofenac in hyaluronic acid gel: an alternative treatment for actinic cheilitis.

Authors:  Giana da Silveira Lima; Gabriela Ferrari da Silva; Ana Paula Neutzling Gomes; Lenita Maria Aver de Araújo; Fernanda Gonçalves Salum
Journal:  J Appl Oral Sci       Date:  2010 Sep-Oct       Impact factor: 2.698

Review 3.  Laser Therapy for the Treatment of Actinic Cheilitis: A Systematic Review.

Authors:  Angela Ayen-Rodriguez; Maria Jose Naranjo-Diaz; Ricardo Ruiz-Villaverde
Journal:  Int J Environ Res Public Health       Date:  2022-04-11       Impact factor: 4.614

4.  A study of actinic cheilitis treatment by two low-morbidity CO2 laser vaporization one-pass protocols.

Authors:  Flávio Francisco de Godoy Peres; Adriana Aigotti Haberbeck Brandão; Yasmin Rodarte Carvalho; Ulysses Dória Filho; Hélio Plapler
Journal:  Lasers Med Sci       Date:  2008-06-14       Impact factor: 3.161

Review 5.  Paying more than lip service to lip lesions.

Authors:  Janna M Bentley; Benjamin Barankin; Gilles J Lauzon
Journal:  Can Fam Physician       Date:  2003-09       Impact factor: 3.275

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.